APP and Alzheimer disease: Moreover, aged transgenic AD mice overexpressing APP/Aβ treated with ginsenoside Rg1 showed marked decrease in cerebral Aβ levels, reversal of neuropathological changes and protection of spatial learning abilities and memory (Fang et al., 2012).